| Investor | Bb Biotech Ag |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Bb Biotech Ag . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2025-06-13 | 13G/A | MGNX / MacroGenics, Inc. | 9,929,963 | 0 | ||||
| 2025-06-13 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 3,515,150 | 0 | ||||
| 2025-03-21 | 13G/A | BDTX / Black Diamond Therapeutics, Inc. | 8,517,839 | 2,733,547 | ||||
| 2025-03-10 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 9,944,064 | 9,694,064 | ||||
| 2025-02-14 | 13G/A | MGNX / MacroGenics, Inc. | 9,929,963 | 9,929,963 | ||||
| 2025-02-14 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 9,194,064 | 9,944,064 | ||||
| 2025-02-14 | 13G/A | BDTX / Black Diamond Therapeutics, Inc. | 8,517,839 | 8,517,839 | ||||
| 2025-02-14 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 4,000,000 | 3,515,150 | ||||
| 2025-01-17 | 13G/A | SAGE / Sage Therapeutics, Inc. | 4,460,693 | 1,178,503 | ||||
| 2024-12-09 | 13G/A | GBIO / Generation Bio Co. | 3,608,280 | 3,310,869 | ||||
| 2024-11-18 | 13G/A | MTEM / Molecular Templates, Inc. | 1,029,820 | 904,001 | ||||
| 2024-11-14 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 8,590,000 | 7,850,000 | ||||
| 2024-11-14 | 13G/A | EPIX / ESSA Pharma Inc. | 7,879,583 | 0 | ||||
| 2024-11-14 | 13G/A | ANNX / Annexon, Inc. | 4,682,290 | 5,157,290 | ||||
| 2024-11-14 | 13G/A | SAGE / Sage Therapeutics, Inc. | 3,505,000 | 4,460,693 | ||||
| 2024-04-22 | 13G | ANNX / Annexon, Inc. | 4,682,290 | |||||
| 2024-02-13 | 13G/A | MTEM / Molecular Templates, Inc. | 1,029,820 | |||||
| 2024-02-13 | 13G/A | WVE / Wave Life Sciences Ltd. | 4,494,458 | 4,494,458 | ||||
| 2024-02-13 | 13G/A | SAGE / Sage Therapeutics, Inc. | 3,100,278 | 3,505,000 | ||||
| 2024-02-13 | 13G/A | GBIO / Generation Bio Co. | 3,608,280 | 3,608,280 | ||||
| 2024-02-13 | 13G/A | MGNX / MacroGenics, Inc. | 8,929,963 | 9,929,963 | ||||
| 2024-02-13 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 9,635,000 | 8,590,000 | ||||
| 2024-02-13 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 4,030,792 | 4,000,000 | ||||
| 2024-02-13 | 13G/A | RVMD / Revolution Medicines, Inc. | 4,777,562 | 5,046,700 | ||||
| 2024-02-13 | 13G/A | BDTX / Black Diamond Therapeutics, Inc. | 5,377,839 | 8,517,839 | ||||
| 2024-02-13 | 13G/A | EPIX / ESSA Pharma Inc. | 7,879,583 | 7,879,583 | ||||
| 2024-01-24 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 4,194,064 | 9,194,064 | ||||
| 2024-01-24 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 4,194,064 | 4,194,064 | ||||
| 2023-02-17 | 13G | SAGE / Sage Therapeutics, Inc. | 2,950,278 | 3,100,278 | ||||
| 2023-02-14 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 4,312,292 | 4,030,792 | ||||
| 2023-02-14 | 13G/A | MTEM / Molecular Templates, Inc. | 10,792,003 | 11,192,003 | ||||
| 2023-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 2,275,125 | 2,132,725 | ||||
| 2023-02-14 | 13G/A | SAGE / Sage Therapeutics, Inc. | 3,170,104 | 2,950,278 | ||||
| 2023-02-14 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 4,477,964 | 4,194,064 | ||||
| 2023-02-14 | 13G/A | GBIO / Generation Bio Co. | 3,853,180 | 3,608,280 | ||||
| 2023-02-14 | 13G/A | MYOV / Myovant Sciences Ltd | 6,122,039 | 5,872,639 | ||||
| 2023-02-14 | 13G/A | MRSN / Mersana Therapeutics, Inc. | 4,135,000 | 4,066,200 | ||||
| 2023-02-14 | 13G/A | KZR / Kezar Life Sciences, Inc. | 4,918,148 | 3,000,000 | ||||
| 2023-02-14 | 13G/A | RVMD / Revolution Medicines, Inc. | 4,602,562 | 4,777,562 | ||||
| 2023-02-14 | 13G/A | EPIX / ESSA Pharma Inc. | 5,015,814 | 7,879,583 | ||||
| 2023-02-14 | 13G/A | BDTX / Black Diamond Therapeutics, Inc. | 3,988,402 | 5,377,839 | ||||
| 2023-02-14 | 13G/A | WVE / Wave Life Sciences Ltd. | 4,602,858 | 4,494,458 | ||||
| 2023-02-14 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 10,232,973 | 9,635,000 | ||||
| 2023-02-14 | 13G/A | MGNX / MacroGenics, Inc. | 7,275,564 | 8,929,963 | ||||
| 2022-09-30 | 13G | RVMD / Revolution Medicines, Inc. | 4,602,562 | 4,602,562 | ||||
| 2022-08-30 | 13D/A | RDUS / Radius Recycling, Inc. | 8,255,714 | 0 | ||||
| 2022-04-14 | 13G/A | BDTX / Black Diamond Therapeutics, Inc. | 3,440,000 | 3,988,402 | ||||
| 2022-02-11 | 13G/A | MTEM / Molecular Templates, Inc. | 9,542,621 | 10,792,003 | ||||
| 2022-02-11 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 2,822,495 | 0 | ||||
| 2022-02-11 | 13G/A | BDTX / Black Diamond Therapeutics, Inc. | 1,900,000 | 3,440,000 | ||||
| 2022-02-11 | 13G/A | SRRK / Scholar Rock Holding Corporation | 2,255,651 | 2,275,125 | ||||
| 2022-02-11 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 8,220,000 | 10,232,973 | ||||
| 2022-02-11 | 13G/A | GBIO / Generation Bio Co. | 2,393,180 | 3,853,180 | ||||
| 2022-02-11 | 13G/A | KZR / Kezar Life Sciences, Inc. | 4,533,148 | 4,918,148 | ||||
| 2022-02-11 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 4,158,902 | 4,312,292 | ||||
| 2022-02-11 | 13G/A | WVE / Wave Life Sciences Ltd. | 2,602,858 | 4,602,858 | ||||
| 2022-02-11 | 13G/A | EPIX / ESSA Pharma Inc. | 4,765,814 | 5,015,814 | ||||
| 2022-02-11 | 13G/A | MYOV / Myovant Sciences Ltd | 4,757,039 | 6,122,039 | ||||
| 2022-02-11 | 13G/A | SAGE / Sage Therapeutics, Inc. | 2,960,104 | 3,170,104 | ||||
| 2022-02-11 | 13G/A | MGNX / MacroGenics, Inc. | 6,025,564 | 7,275,564 | ||||
| 2022-02-11 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 4,477,964 | 4,477,964 | ||||
| 2022-02-11 | 13G/A | VYGR / Voyager Therapeutics, Inc. | 2,680,283 | 0 | ||||
| 2022-01-18 | 13D/A | RDUS / Radius Recycling, Inc. | 7,455,714 | 8,255,714 | ||||
| 2021-09-16 | 13G | MRSN / Mersana Therapeutics, Inc. | 4,135,000 | 4,135,000 | ||||
| 2021-08-17 | 13G/A | EPIX / ESSA Pharma Inc. | 1,985,814 | 4,765,814 | ||||
| 2021-08-11 | 13G | SAGE / Sage Therapeutics, Inc. | 2,960,104 | |||||
| 2021-06-11 | 13G/A | MGNX / MacroGenics, Inc. | 4,815,564 | 6,025,564 | ||||
| 2021-05-28 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 4,477,964 | 4,477,964 | ||||
| 2021-05-27 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 3,947,964 | 4,477,964 | ||||
| 2021-05-05 | 13G | EPIX / ESSA Pharma Inc. | 1,985,814 | |||||
| 2021-04-26 | 13G/A | MTEM / Molecular Templates, Inc. | 6,380,331 | 9,542,621 | ||||
| 2021-02-12 | 13G/A | ITCI / Intra-Cellular Therapies, Inc. | 3,458,419 | 3,538,419 | ||||
| 2021-02-12 | 13G/A | MTEM / Molecular Templates, Inc. | 5,229,996 | 6,380,331 | ||||
| 2021-02-12 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 7,963,056 | 3,970,000 | ||||
| 2021-02-12 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 3,727,964 | 3,947,964 | ||||
| 2021-02-12 | 13G/A | SRRK / Scholar Rock Holding Corporation | 2,634,466 | 2,255,651 | ||||
| 2021-02-12 | 13G/A | KZR / Kezar Life Sciences, Inc. | 1,550,669 | 4,533,148 | ||||
| 2021-02-12 | 13G/A | VYGR / Voyager Therapeutics, Inc. | 2,680,283 | 2,680,283 | ||||
| 2021-02-12 | 13G/A | WVE / Wave Life Sciences Ltd. | 2,402,858 | 2,602,858 | ||||
| 2021-02-12 | 13G/A | MYOV / Myovant Sciences Ltd | 4,815,109 | 4,757,039 | ||||
| 2021-02-12 | 13G/A | MGNX / MacroGenics, Inc. | 4,519,159 | 4,815,564 | ||||
| 2021-02-12 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 2,295,272 | 2,822,495 | ||||
| 2021-02-12 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 3,896,954 | 4,158,902 | ||||
| 2021-02-12 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 7,994,955 | 8,220,000 | ||||
| 2021-02-11 | 13G | BDTX / Black Diamond Therapeutics, Inc. | 1,900,000 | |||||
| 2021-01-08 | 13G | GBIO / Generation Bio Co. | 2,393,180 | |||||
| 2020-11-17 | 13D/A | RDUS / Radius Recycling, Inc. | 6,931,685 | 7,455,714 | ||||
| 2020-11-04 | 13G/A | MTEM / Molecular Templates, Inc. | 5,229,996 | 5,229,996 | ||||
| 2020-11-03 | 13G/A | MTEM / Molecular Templates, Inc. | 2,161,152 | 5,229,996 | ||||
| 2020-05-19 | 13D/A | RDUS / Radius Recycling, Inc. | 6,372,322 | 6,931,685 | ||||
| 2020-02-14 | 13G/A | WVE / Wave Life Sciences Ltd. | 1,902,858 | 2,402,858 | ||||
| 2020-02-14 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 2,295,272 | 2,295,272 | ||||
| 2020-02-14 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 2,978,134 | 3,896,954 | ||||
| 2020-02-14 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 3,392,964 | 3,727,964 | ||||
| 2020-02-14 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 8,741,334 | 7,994,955 | ||||
| 2020-02-14 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 8,322,860 | 7,963,056 | ||||
| 2020-02-14 | 13G/A | KZR / Kezar Life Sciences, Inc. | 974,496 | 1,550,669 | ||||
| 2020-02-14 | 13G/A | MGNX / MacroGenics, Inc. | 3,283,272 | 4,519,159 | ||||
| 2020-02-14 | 13G/A | MYOV / Myovant Sciences Ltd | 3,597,882 | 4,815,109 | ||||
| 2020-02-14 | 13G/A | VYGR / Voyager Therapeutics, Inc. | 2,865,841 | 2,680,283 | ||||
| 2020-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 1,279,978 | 2,634,466 | ||||
| 2020-02-06 | 13G | ITCI / Intra-Cellular Therapies, Inc. | 2,200,000 | 3,458,419 | ||||
| 2020-01-29 | 13G | MTEM / Molecular Templates, Inc. | 2,161,152 | |||||
| 2019-12-23 | 13G | WVE / Wave Life Sciences Ltd. | 1,902,858 | |||||
| 2019-02-13 | 13G/A | MYOV / Myovant Sciences Ltd | 3,507,882 | 3,597,882 | ||||
| 2019-02-13 | 13G/A | VYGR / Voyager Therapeutics, Inc. | 1,786,341 | 2,865,841 | ||||
| 2019-02-13 | 13G/A | MGNX / MacroGenics, Inc. | 2,600,412 | 3,283,272 | ||||
| 2019-02-13 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 2,822,964 | 3,392,964 | ||||
| 2019-02-13 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 2,295,272 | 2,295,272 | ||||
| 2019-02-13 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 8,520,137 | 8,322,860 | ||||
| 2019-02-13 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 8,136,334 | 8,741,334 | ||||
| 2019-02-13 | 13G/A | TSRO / TESARO, Inc. | 2,811,802 | 0 | ||||
| 2019-01-31 | 13G | KZR / Kezar Life Sciences, Inc. | 974,496 | |||||
| 2019-01-28 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 2,719,998 | 2,978,134 | ||||
| 2019-01-07 | 13G | SRRK / Scholar Rock Holding Corporation | 1,279,978 | |||||
| 2018-08-13 | 13G | TSRO / TESARO, Inc. | 2,811,802 | |||||
| 2018-08-06 | 13D/A | RDUS / Radius Recycling, Inc. | 5,677,322 | 6,372,322 | ||||
| 2018-05-10 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 2,362,964 | 2,822,964 | ||||
| 2018-02-14 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 6,913,172 | 8,136,334 | ||||
| 2018-02-14 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 1,308,542 | 2,362,964 | ||||
| 2018-02-14 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 7,599,832 | 8,520,137 | ||||
| 2018-02-14 | 13G/A | MGNX / MacroGenics, Inc. | 1,920,000 | 2,600,412 | ||||
| 2018-02-14 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 2,235,272 | 2,295,272 | ||||
| 2018-02-14 | 13G/A | MYOV / Myovant Sciences Ltd | 3,192,835 | 3,507,882 | ||||
| 2018-02-14 | 13G/A | ITCI / Intra-Cellular Therapies, Inc. | 2,200,000 | 2,200,000 | ||||
| 2018-02-14 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 2,809,528 | 2,719,998 | ||||
| 2018-01-10 | 13G | VYGR / Voyager Therapeutics, Inc. | 1,786,341 | |||||
| 2017-10-27 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 1,043,824 | 2,235,272 | ||||
| 2017-09-20 | 13D/A | RDUS / Radius Recycling, Inc. | 5,217,322 | 5,677,322 | ||||
| 2017-08-23 | 13G | ITCI / Intra-Cellular Therapies, Inc. | 2,200,000 | |||||
| 2017-06-01 | 13D/A | RDUS / Radius Recycling, Inc. | 4,718,922 | 5,217,322 | ||||
| 2017-03-22 | 13D/A | RDUS / Radius Recycling, Inc. | 4,718,922 | |||||
| 2017-02-14 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 6,529,838 | 6,913,172 | ||||
| 2017-02-14 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 2,159,921 | 2,809,528 | ||||
| 2017-02-14 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 7,029,832 | 7,599,832 | ||||
| 2017-02-14 | 13G/A | CDTX / Cidara Therapeutics, Inc. | 746,824 | 1,043,824 | ||||
| 2017-02-14 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 1,158,542 | 1,308,542 | ||||
| 2017-02-14 | 13G/A | MGNX / MacroGenics, Inc. | 1,800,000 | 1,920,000 | ||||
| 2017-02-14 | 13G/A | MYOV / Myovant Sciences Ltd | 3,086,929 | 3,192,835 | ||||
| 2017-02-14 | 13G/A | INFI / Infinity Pharmaceuticals Inc. | 2,700,737 | 0 | ||||
| 2016-12-29 | 13G | MGNX / MacroGenics, Inc. | 1,800,000 | |||||
| 2016-12-28 | 13G | MYOV / Myovant Sciences Ltd | 3,086,929 | |||||
| 2016-09-27 | 13G | ESPR / Esperion Therapeutics, Inc. | 1,158,542 | |||||
| 2016-04-04 | 13G | CDTX / Cidara Therapeutics, Inc. | 746,824 | |||||
| 2016-02-09 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 6,529,838 | |||||
| 2016-02-09 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 2,159,921 | |||||
| 2016-02-09 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 7,029,832 | |||||
| 2016-02-09 | 13G/A | INFI / Infinity Pharmaceuticals Inc. | 2,700,737 | |||||
| 2015-02-13 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 6,825,532 | |||||
| 2015-02-12 | 13G/A | AGIO / Agios Pharmaceuticals, Inc. | 1,864,921 | |||||
| 2015-02-12 | 13G/A | ECYT / Endocyte, Inc. | 0 | |||||
| 2015-02-12 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 5,976,526 | |||||
| 2015-01-13 | 13G | INFI / Infinity Pharmaceuticals Inc. | 2,520,737 | |||||
| 2014-09-11 | 13G | AGIO / Agios Pharmaceuticals, Inc. | 1,745,521 | |||||
| 2014-08-07 | 13G | HALO / Halozyme Therapeutics, Inc. | 6,271,564 | |||||
| 2014-06-12 | 13D/A | RDUS / Radius Recycling, Inc. | 2,883,563 | |||||
| 2014-03-05 | 13D/A | RDUS / Radius Recycling, Inc. | 3,374,927 | |||||
| 2014-02-12 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 6,417,548 | |||||
| 2014-02-12 | 13G/A | ECYT / Endocyte, Inc. | 2,643,522 | |||||
| 2014-02-12 | 13G/A | HALO / Halozyme Therapeutics, Inc. | 4,724,936 | |||||
| 2013-08-14 | 13G | HALO / Halozyme Therapeutics, Inc. | 5,746,519 | |||||
| 2013-05-03 | 13D/A | RDUS / Radius Recycling, Inc. | 2,531,888 | |||||
| 2013-02-13 | 13G/A | IMGN / ImmunoGen, Inc. | 3,551,432 | |||||
| 2013-02-13 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 8,043,140 | |||||
| 2013-02-13 | 13G/A | ECYT / Endocyte, Inc. | 2,063,352 | |||||
| 2012-08-08 | 13G | ECYT / Endocyte, Inc. | 1,823,593 | |||||
| 2012-02-07 | 13G/A | IMGN / ImmunoGen, Inc. | 4,000,000 | |||||
| 2012-02-07 | 13G/A | IONS / Ionis Pharmaceuticals, Inc. | 7,233,800 | |||||
| 2012-02-07 | 13G/A | MITI / Mitesco, Inc. | 6,681,397 | |||||
| 2012-02-07 | 13G/A | OPTR / Optimer Pharmaceuticals Inc | 1,442,700 | |||||
| 2012-01-03 | 13D/A | RDUS / Radius Recycling, Inc. | 1,228,200 |
